ApcinteX Company Profile: Funding, Investors & Partnerships

ApcinteX

Subscribe
Submit Feedback
Claim

ApcinteX

Claim

ApcinteX develops and markets anticoagulant APC pathways to treat haemophilia.ApcinteX develops and markets anticoagulant APC pathways to treat haemophilia.

Alpha Score

N/A

Alpha Score

N/A

Predictions
Overview
Team
Financials
Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes

0and0

About

About Contact Us Knowledge Center

Legal

Terms & Conditions Privacy

Connect With Us

Copyright 2026 | Galen Growth | All Right Reserved